8:30 AM - 8:40 AM Introduction

8:40 AM - 10:30 AM Session 1: Cardiogenic Shock: Time for paradigm shift!

10:50 AM - 12:00 PM Session 2: Cardiogenic Shock: Inflammation: a driver of outcome

1:00 PM - 3:20 PM Session 3: Improve Cardiogenic Shock trial design to prevent neutral trial

3:40 PM - 4:50 PM Session 4: Ongoing studies

5:00 PM - 6:45 PM Session 5: Positive trials in critical care: the key role of regulators

8:30 AM - 8:40 AM Introduction

8:40 AM - 11:00 AM Session 6: Acute Heart Failure: What trials are still needed?

11:00 AM - 1:00 PM Session 7: Management of massive bleeding

2:00 - 4:30 PM Session 8: Improving outcomes in the critically ill patients: AI and physicians working hand-in-hand

4:30 - 7:00 PM Session 9: ARDS 2024 guidelines shape trial design

8:30 - 8:35 AM Welcome introduction by Alexandre Mebazaa

8:35 AM - 10:40 AM Session 10: Sepsis I: Endotype-guided therapy

11:00 AM - 1:00 PM Session 11: Sepsis II: Trialists and regulators: can we agree on an endpoint?